Coates International, Inc. is an integrated hemp and cannabis extraction, research and manufacturing company focused on the development of proprietary cannabinoid compounds, formulations and derivative products. Through its network of licensed facilities, the company provides turnkey extraction and purification services to commercial producers, pharmaceutical developers and consumer packaged goods companies. Coates International’s platform combines scalable extraction technologies—including supercritical CO2, ethanol and hydrocarbon methods—with analytical chemistry and process engineering to deliver consistent, high-purity cannabinoid isolates and concentrates.
The company’s product portfolio spans a broad spectrum of applications, from nutraceuticals and wellness supplements to pharmaceutical-grade formulations. Key offerings include CBD, CBG and CBN isolates, full- and broad-spectrum hemp extracts, distillates and water-soluble emulsions for beverages and tinctures. Coates International also supports contract manufacturing and white-label production of capsules, soft gels, topicals and infused edibles. Its research arm collaborates with academic institutions and biotech firms to explore novel therapeutic uses of minor cannabinoids and to optimize production yields.
Founded in 2014 and headquartered in North Carolina, Coates International has expanded operations to serve markets in the United States, Canada and select international jurisdictions. The company holds state and federal permits for hemp processing and has recently secured Health Canada licensing to facilitate cross-border supply for clinical trial programs. In addition, Coates maintains strategic partnerships with distribution networks in Europe and Australia to extend its reach into emerging medical cannabis markets. Its ISO-certified laboratories and GMP-compliant facilities support both small-batch research initiatives and large-scale production runs.
Leadership at Coates International is spearheaded by founder and CEO Kenneth Coates, an environmental engineer with over two decades of experience in process design and regulatory compliance. The executive team includes seasoned professionals in pharmaceutical development, quality assurance, and botanical analytics, underscoring the company’s commitment to rigorous scientific standards. Guided by a multidisciplinary advisory board, Coates International continues to invest in innovation and scale its capabilities to meet the evolving demands of the global cannabinoid industry.
AI Generated. May Contain Errors.
Free COTE Stock Alerts